ITI Securities Broking Ltd

Change Company Name

Biocon Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532523	ISIN Demat INE376G01013	Book Value 168.03	NSE Symbol BIOCON	Div & Yield % 0.14	Market Cap (₹ Cr.) 59,769.03	P/E 185.23	EPS 1.98	Face Value 5

Particulars	Sep 2026	Jun 2026	Mar 2026	Dec 2025
	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Gross Sales	630.50	624.50	604.70	621.30
Other Operating Income	0.00	0.00	0.00	0.00
Other Income	90.70	64.80	49.80	74.80
Total Income	721.20	689.30	654.50	696.10
Total Expenditure	541.30	563.70	544.20	744.30
PBIDT	179.90	125.60	110.30	-48.20
Interest	21.90	17.30	16.70	2.30
PBDT	158.00	108.30	93.60	-50.50
Depreciation	38.20	38.40	36.20	34.00
Tax	25.30	16.70	-1.20	8.90
Fringe Benefit Tax	0.00	0.00	0.00	0.00
Deferred Tax	2.80	1.00	7.60	-17.00
Reported Profit After Tax	91.70	52.20	51.00	-76.40
Extra-ordinary Items	0.00	0.00	-16.31	-187.40
Adjusted Profit After Extra-ordinary item	91.70	52.20	67.31	111.00

EPS (Unit Curr.)	0.56	0.32	0.32	-0.57
EPS (Adj) (Unit Curr.)	0.56	0.32	0.32	-0.57
Calculated EPS (Unit Curr.)	0.56	0.32	0.31	-0.57
Calculated EPS (Adj) (Unit Curr.)	0.56	0.32	0.31	-0.57
Calculated EPS (Ann.) (Unit Curr.)	2.25	1.28	1.26	-2.29
Calculated EPS (Adj) (Ann.) (Unit Curr.)	2.25	1.28	1.26	-2.29
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
Equity	814.80	814.80	810.50	668.50
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	5.00	5.00	5.00	5.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

PBIDTM(%)	28.53	20.11	18.24	-7.76
PBDTM(%)	25.06	17.34	15.48	-8.13
PATM(%)	14.54	8.36	8.43	-12.30
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00
Diluted EPS	0.56	0.32	0.32	-0.57

Quarterly Results

Market

News

Research

TECHNICAL

FUNDAMENTAL

Products

Attention Investors